Alkermes plc. (ALKS): who owns it and who trades it
As of Nov 16, 2026, ALKS insiders reported 33 open-market sales worth $10.1M and no purchases in the last 12 months, with 71% of the sale value made under pre-set 10b5-1 plans. The largest seller was Craig C. Hopkinson (Vice president), with $3.4M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Alkermes
From the latest filingsOverall: more buying than selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ALKS
422 funds and institutions reported ALKS shares worth $9.6B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 17.5%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 29.24M | 17.54% | $1.5B | +3% |
| California State Teachers Retirement System | 10.34M | 6.21% | $197M | +5528% |
| Baker Bros. Advisors LP | 10.01M | 6.01% | $525M | No change |
| Vanguard Portfolio Management LLC | 9.49M | 5.69% | $497M | -0% |
| State Street Corp | 9.16M | 5.50% | $480M | -3% |
| Vanguard Capital Management LLC | 7.52M | 4.51% | $394M | +1% |
| T. Rowe Price Associates | 6.74M | 4.04% | $353M | +44% |
| Renaissance Technologies LLC | 6.46M | 3.88% | $339M | +5% |
| Geode Capital Management, LLC | 4.48M | 2.69% | $235M | +7% |
| Dimensional Fund Advisors LP | 4.19M | 2.52% | $220M | -7% |
| Deep Track Capital, LP | 4.00M | 2.40% | $210M | +11% |
| American Century Companies Inc | 3.95M | 2.37% | $207M | -35% |
| Holocene Advisors, LP | 3.60M | 2.16% | $189M | +55% |
| Commodore Capital LP | 3.00M | 1.80% | $157M | -29% |
| Wellington Management Group LLP | 2.81M | 1.69% | $147M | -5% |
| Primecap Management Co | 2.53M | 1.52% | $132M | -0% |
| First Trust Advisors LP | 2.42M | 1.45% | $127M | -18% |
| Charles Schwab Investment Management Inc | 2.34M | 1.40% | $122M | +4% |
| Sixth Street Partners Management Company, L.P. | 2.34M | 1.40% | $122M | – |
| Nuveen, LLC | 2.32M | 1.39% | $122M | -6% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ALKS insiders reported $0 of open-market purchases and $10.1M of sales. 71% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,035 | $46.17 | $94K | Form 4 |
| Oct 2, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $41.03 | $83.5K | Form 4 |
| Sep 3, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $48.01 | $97.7K | Form 4 |
| Sep 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $46.99 | $423K | Form 4 |
| Aug 17, 2026 | Christian Todd Nichols | Vice president | Sale plan | 664 | $49.65 | $33K | Form 4 |
| Aug 17, 2026 | Christian Todd Nichols | Vice president | Sale plan | 6,912 | $49.19 | $340K | Form 4 |
| Aug 3, 2026 | nancy lynn MD snyderman | Director | Sale | 44,472 | $50.35 | $2.2M | Form 4 |
| Aug 3, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $48.58 | $437K | Form 4 |
| Aug 3, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $48.58 | $98.8K | Form 4 |
| Jul 6, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $54.03 | $110K | Form 4 |
| Jul 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 700 | $52.13 | $36.5K | Form 4 |
| Jul 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 8,300 | $51.46 | $427K | Form 4 |
| Jun 12, 2026 | Christopher I Wright | Director | Sale plan | 2,000 | $45.10 | $90.2K | Form 4 |
| Jun 4, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $43.05 | $87.6K | Form 4 |
| Jun 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $41.67 | $375K | Form 4 |
| May 29, 2026 | Samuel Joseph Parisi | Vice president | Sale | 16,217 | $42.36 | $687K | Form 4 |
| May 4, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $33.20 | $67.5K | Form 4 |
| May 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $33.40 | $301K | Form 4 |
| Apr 6, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $34.57 | $70.3K | Form 4 |
| Apr 1, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $35.51 | $320K | Form 4 |
| Mar 3, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $29.76 | $60.5K | Form 4 |
| Mar 2, 2026 | Samuel Joseph Parisi | Vice president | Sale plan | 6,890 | $29.29 | $202K | Form 4 |
| Mar 2, 2026 | Christian Todd Nichols | Vice president | Sale plan | 6,000 | $30.00 | $180K | Form 4 |
| Mar 2, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 9,000 | $29.72 | $267K | Form 4 |
| Mar 2, 2026 | David Joseph Gaffin | Vice president | Sale plan | 2,034 | $29.29 | $59.6K | Form 4 |
| Feb 2, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 5,000 | $34.24 | $171K | Form 4 |
| Feb 2, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 4,000 | $33.54 | $134K | Form 4 |
| Feb 2, 2026 | Shane Cooke | Director | Sale plan | 32,113 | $34.78 | $1.1M | Form 4 |
| Feb 2, 2026 | Shane Cooke | Director | Sale plan | 29,087 | $34.34 | $999K | Form 4 |
| Jan 8, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 5,000 | $30.00 | $150K | Form 4 |
| Jan 2, 2026 | Craig C. Hopkinson | Vice president | Sale plan | 4,000 | $28.00 | $112K | Form 4 |
| Dec 3, 2025 | Craig C. Hopkinson | Vice president | Sale plan | 3,748 | $30.00 | $112K | Form 4 |
| Dec 1, 2025 | Craig C. Hopkinson | Vice president | Sale plan | 4,000 | $29.30 | $117K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | – | $3.4M | Sep 1, 2026 |
| nancy lynn MD snyderman | Director | – | $2.2M | Aug 3, 2026 |
| Shane Cooke | Director | – | $2.1M | Feb 2, 2026 |
| Samuel Joseph Parisi | VP, Finance (Interim PAO) | – | $889K | May 29, 2026 |
| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | – | $829K | Nov 3, 2026 |
| Christian Todd Nichols | SVP, Chief Commercial Officer | – | $553K | Aug 17, 2026 |
| Christopher I Wright | Director | – | $90.2K | Jun 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ALKS short interest
High short interest. 11.7% of ALKS shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 7%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 19.65M ALKS shares were sold short, 11.7% of the shares outstanding, up 3.1% from the report before. At the average daily volume of 1.75M shares, buying them all back would take about 11.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 19.65M | 11.69% | +3% | 1.75M | 11.2 |
| Oct 15, 2026 | 19.05M | 11.35% | +7% | 2.09M | 9.1 |
| Sep 30, 2026 | 17.82M | 10.62% | +18% | 2.84M | 6.3 |
| Sep 15, 2026 | 15.16M | 9.03% | +3% | 1.42M | 10.7 |
| Aug 31, 2026 | 14.72M | 8.77% | -0% | 1.25M | 11.8 |
| Aug 14, 2026 | 14.76M | 8.80% | +2% | 1.45M | 10.2 |
| Jul 31, 2026 | 14.41M | 8.59% | -4% | 1.87M | 7.7 |
| Jul 15, 2026 | 15.02M | 9.01% | -14% | 1.65M | 9.1 |
| Jun 30, 2026 | 17.46M | 10.48% | -3% | 3.63M | 4.8 |
| Jun 15, 2026 | 17.96M | 10.78% | +4% | 1.90M | 9.5 |
| May 29, 2026 | 17.36M | 10.41% | -5% | 2.05M | 8.4 |
| May 15, 2026 | 18.28M | 10.97% | -8% | 2.42M | 7.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded ALKS
Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 0 sales of ALKS. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.
Purchases 2Sales 0
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Oct 12, 2026 | Report |
| Jul 30, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $15K–$50K | Self | Sep 4, 2026 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Alkermes company events
Alkermes filed 17 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 3, 2026.
- Nov 3, 2026ResultsReleased financial results. Filing
- Sep 21, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
- Sep 16, 2026LeadershipThe board of directors of Alkermes plc increased the size of the Board from ten (10) to eleven (11) directors and appointed Anne C. Whitaker to the Board, effective immediately, with an initial term expiring at the Company’s 2027 annual general meeting of shareholders. Filing
- Aug 12, 2026AgreementAlkermes plc entered into Amendment No. 1 to Credit Agreement, which amends the Credit Agreement, dated as of February 12, 2026, among the Company, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, Alkermes Finance LLC, as the U.S. Co-Borrower, JPMorgan Chase Bank, N.A., as… Filing
- Aug 3, 2026LeadershipAmended an earlier report. Of the Original Form 8-K to provide information regarding additional actions taken by the Board in connection with Mr. Jackson’s appointment, including (i) information regarding the compensation awarded to Mr. Jackson, which was not yet determined at the time of filing of the Original Form 8-K and… Filing
- Jul 28, 2026ResultsReleased financial results. Filing
- Jul 8, 2026AgreementEnded an important agreement. Filing
- Jun 15, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the related press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
- May 20, 2026LeadershipAt the 2026 annual general meeting of shareholders of Alkermes plc, the Company’s shareholders approved amendments to the Alkermes plc 2018 Stock Option and Incentive Plan to, among other things, increase the number of the Company’s ordinary shares authorized for issuance thereunder by 5,900,000… Filing
- May 12, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Feb 25, 2026LeadershipRichard F. Pops, Chairman and Chief Executive Officer of Alkermes plc, notified the Company’s board of directors of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role. Filing
- Feb 25, 2026ResultsReleased financial results. Filing
- Feb 12, 2026DealBelow) and the Company’s entry into the Credit Agreement (as described in Item 1.01 above), the Company terminated the previously disclosed amended and restated bridge term loan credit agreement by and among the Company, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, JPMorgan Chase… Filing
- Jan 12, 2026ResultsReleased financial results. Filing
- Jan 6, 2026AnnouncementOf this Current Report on Form 8-K. A copy of the related press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. Filing
- Nov 19, 2025AgreementAlkermes plc and Avadel Pharmaceuticals plc entered into Amendment No. 1 to the previously announced Transaction Agreement dated October 22, 2025 by and between Alkermes and Avadel (the “Original Transaction Agreement” and, as amended by the Amendment, the “Amended Transaction Agreement”). Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Alkermes financials
Famous investors that hold ALKS
5 of the 50 well-known investors we track reported holding ALKS in their latest 13F filing. The largest position is Jim Simons's, worth $263M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 6.49M | $263M | 0.4% | +1% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.73M | $70.1M | 0.0% | +5% |
| Israel Englander · Millennium Management | Q3 2026 | 481,919 | $19.5M | 0.0% | +51% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 433,263 | $17.6M | 0.0% | +3% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 87,074 | $3.5M | 0.0% | +236% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Alkermes plc. (ALKS) stock
Who owns the most ALKS stock?
The largest reported owner of Alkermes plc. (ALKS) is BlackRock, Inc., with 17.5% of the company. In total, 422 funds and institutions reported holding ALKS at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are ALKS insiders buying or selling?
In the last 12 months, ALKS insiders reported no open-market purchases and 33 sales worth $10.1M. The latest trade was on Nov 3, 2026. See every trade.
What is the short interest in ALKS?
As of Oct 30, 2026, 19.65M ALKS shares were sold short, 11.7% of the shares outstanding, up 3.1% from the report before. At the average daily volume of 1.75M shares, buying them all back would take about 11.2 trading days (days to cover). See the history.
Have members of Congress traded ALKS?
Yes. 1 member of Congress reported 2 purchases and 0 sales of ALKS since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.
Which famous investors hold ALKS?
5 of the 50 well-known investors we track reported ALKS in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $263M. See all holders.
Executive pay
Alkermes's chief executive was paid a total of $7.9M for the year ended Dec 31, 2025, down 22% from $10.1M the year before. In the last 12 months, Alkermes's executives and directors bought no stock on the open market and sold $10.1M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.